End of the beginning and public health pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine

dc.contributor.authorOzdemir V.
dc.contributor.authorFisher E.
dc.contributor.authorDove E.S.
dc.contributor.authorBurton H.
dc.contributor.authorWright G.E.B.
dc.contributor.authorMasellis M.
dc.contributor.authorWarnich L.
dc.date.accessioned2012-05-17T09:01:00Z
dc.date.available2012-05-17T09:01:00Z
dc.date.issued2012
dc.description.abstract[No abstract available]
dc.identifier.citationCurrent Pharmacogenomics and Personalized Medicine
dc.identifier.citation10
dc.identifier.citation1
dc.identifier.citation1
dc.identifier.citation6
dc.identifier.issn18756921
dc.identifier.urihttp://hdl.handle.net/10019.1/21085
dc.titleEnd of the beginning and public health pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine
dc.typeEditorial
Files